por Gus Iversen
, Editor in Chief | December 30, 2020
Siemens Healthineers acquires Varian for $16.4 billion
In early August, Siemens Healthineers announced a blockbuster deal to acquire Varian Medical Systems
, the market leader in radiotherapy technology. The deal, which cost Siemens $16.4 billion, brings together two medical equipment companies with a long track record of collaboration.
"This decisive moment in the history of our companies means more hope and less uncertainty for patients, an even stronger partner for our customers, and for society, more effective and efficient medical care," said Bernd Montag, CEO of Siemens Healthineers, in a statement. "Together with Varian's outstanding and passionate employees, we will shape the future of healthcare more than ever before."
Midwest Hand Surgery Auction Closing 5/26 at 8PM. Hologic Fluoroscan Insight-FD Mini C-Arm, Nuvo Dual-Lamp Surgical Lighting System W/Control Panel, Ritter M11 Ultraclave Automatic Sterilizer & More! 2 Day Women's Treatment Center Auction Coming Soon!
Based in Palo Alto, Varian is the leader in radiation oncology technology with a market share of over 50%, according to Reuters. This market, which includes cutting-edge cancer treatment technology like linear accelerators and proton therapy systems, is poised for growth as the World Health Organization's International Agency for Research on Cancer expects the prevalence of cancer to almost double between 2010 and 2030, with most cancer patients undergoing radiotherapy.
Siemens previously had a stake in the radiotherapy market but exited the business in 2011. Starting in 2012, the company entered a strategic partnership with Varian called EnVision Better Cancer Care that brought together their diagnostic and therapeutic solutions.
“Siemens Healthineers values our talented and engaged employees and recognizes the strength of the Varian brand, our cutting-edge portfolio, and the relationships we’ve nurtured," said Varian CEO, Dow Wilson. "We are thrilled to partner with Siemens Healthineers to extend our renowned customer care, serving clinicians and patients from the very first stage in the fight against cancer."